1 2 3 4 27

The resulting variation in nutrient intake with the inclusion of walnuts in the diets of adults at risk for type 2 diabetes: A randomized, controlled, crossover trial.

Njike, V.Y., V.C. Costales, P. Petraro, A. Annam, N. Yarandi, D.L. Katz, 2018. The resulting variation in nutrient intake with the inclusion of walnuts in the diets of adults at risk for type 2 diabetes: A randomized, controlled, crossover trial. Am J Health Promot. Aug 1:890117118791120. doi: 10.1177/0890117118791120. [Epub ahead of print]

2019-02-14T20:31:22+00:00Tags: , , |

Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice.

Koh, S.J., Y.I. Choi, Y. Kim, Y.S. Kim, S.W. Choi, J.W. Kim, B.G. Kim, K.L. Lee, 2018. Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice. Eur J Nutr. doi: 10.1007/s00394-018-1704-3.

Walnut consumption alters the gastrointestinal microbiota, microbially derived secondary bile acids, and health markers in healthy adults: a randomized controlled trial.

Holscher, H.D., H.M. Guetterman, K.S. Swanson, R. An,N.R. Matthan, A.H. Lichtenstein, J.A. Novotny, D.J. Baer, 2018. Walnut consumption alters the gastrointestinal microbiota, microbially derived secondary bile acids, and health markers in healthy adults: a randomized controlled trial. J Nutr. doi: 10.1093/jn/nxy004. [Epub ahead of print]

Effects of walnut consumption on blood lipids and other cardiovascular risk factors: an updated meta-analysis and systematic review of controlled trials.

Guasch-Ferré, M., J. Li, F.B. Hu, J. Salas-Salvadó, D.K. Tobias, 2018. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: an updated meta-analysis and systematic review of controlled trials. Am J Clin Nutr. doi: 10.1093/ajcn/nqy091. [Epub ahead of print]

1 2 3 4 27